We are receiving preliminary interest from both a strategic buyer who values us on a multiple of revenue and a financial sponsor who uses a multiple of EBITDA. How do we determine which valuation methodology aligns best with our operational strengths as we prepare for a sale?

Question

Tyler Smith · Accepted Answer

Deciding between a strategic buyer's revenue-based multiple and a financial sponsor's EBITDA-based multiple depends entirely on your company's operational leverage and growth trajectory. A strategic buyer usually values a business on a multiple of revenue because they plan to absorb your operations, cut redundant overhead costs, and cross-sell your products to their existing customer base. If you have built highly proprietary technology or automated systems but have high operating costs that suppress your current EBITDA, a strategic buyer will likely offer a much higher valuation. On the other hand, a financial sponsor values a business on a multiple of EBITDA because they look at your company as a standalone cash-generating engine. If you run a highly efficient, lean operation with strong margins, a healthy cash-to-collection cycle, and a complete leadership team that can scale, a financial sponsor's EBITDA valuation will likely reward your operational efficiency. Use your Business Impact Review to analyze your current cost structure and operational dependencies. If your company requires significant capital expenditure to scale, a strategic sale may yield better net proceeds. If your operations are fully systematized and highly profitable on a standalone basis, a financial sponsor using an EBITDA multiple will recognize the low-risk profile of your systems and offer a premium multiple that reflects your operational excellence.